{
  "id": "clinical#risk_safety_9e22b4c4",
  "content": "The risk may be related to short-term effects of the substance or to longer-term cumulative effects\non physical or mental health or functioning. Hazardous substance use has not yet reached the\nlevel of having caused harm to physical or mental health of the user or others around the user.\nThe pattern of substance use often persists in spite of awareness of increased risk of harm to the\nuser or to others.\nQE10 Hazardous alcohol use\nQE11 Hazardous drug use\nQE11.0 Hazardous use of opioids\nQE11.1 Hazardous use of cannabis\nQE11.2 Hazardous use of sedatives, hypnotics or anxiolytics\nQE11.3 Hazardous use of cocaine\nQE11.4 Hazardous use of stimulants, including amfetamines, methamfetamine and methcathinone\nQE11.5 Hazardous use of caffeine\nQE11.6 Hazardous use of MDMA or related drugs\nQE11.7 Hazardous use of dissociative drugs, including ketamine and PCP\nQE11.8 Hazardous use of other specified psychoactive substance\nQE11.9 Hazardous use of unknown or unspecified psychoactive substances\nQE11.Y Other specified hazardous drug use\nQE11.Z Hazardous drug use, unspecified\nHazardous substance use\n506 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nQE12 Hazardous nicotine use\nDisorders due to addictive behaviours\nDisorders due to addictive behaviours are recognizable and clinically significant syndromes",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety The risk may be related to short-term effects of the substance or to longer-term cumulative effects\non physical or mental health or functioning. Hazardous substance use has not yet reached the\nlevel of having caused harm to physical or mental health of the user or others around the user.\nThe pattern of substance use often persists in spite of awareness of increased risk of harm to the\nuser or to others.\nQE10 Hazardous alcohol use\nQE11 Hazardous drug use\nQE11.0 Hazardous use of opioids\nQE11.1 Hazardous use of cannabis\nQE11.2 Hazardous use of sedatives, hypnotics or anxiolytics\nQE11.3 Hazardous use of cocaine\nQE11.4 Hazardous use of stimulants, including amfetamines, methamfetamine and methcathinone\nQE11.5 Hazardous use of caffeine\nQE11.6 Hazardous use of MDMA or related drugs\nQE11.7 Hazardous use of dissociative drugs, including ketamine and PCP\nQE11.8 Hazardous use of other specified psychoactive substance\nQE11.9 Hazardous use of unknown or unspecified psychoactive substances\nQE11.Y Other specified hazardous drug use\nQE11.Z Hazardous drug use, unspecified\nHazardous substance use\n506 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nQE12 Hazardous nicotine use\nDisorders due to addictive behaviours\nDisorders due to addictive behaviours are recognizable and clinically significant syndromes The nguy cơ may be related to short-term effects of the substance or to longer-term cumulative effects\non physical or mental health or functioning. hazardous substance use has not yet reached the\nlevel of having caused h..."
}